Healthcare Triangle (NASDAQ:HCTI) fell 11.30% in after-hours trading, driven by persistent concerns over its financial performance and valuation. The stock has declined 30% over the past 30 days and 99% annually, with revenue shrinking 22% in the last year and 70% over three years. Despite analyst forecasts of 38% annual growth over the next three years, the market remains skeptical, reflected in a price-to-sales ratio of 0.8x—well below peers in the healthcare services sector. The article highlights weak revenue trends, downward pressure on valuation metrics, and five warning signs cited by analysts, underscoring investor hesitancy despite bullish growth expectations. The after-hours decline aligns with prolonged bearish sentiment surrounding the company’s operational performance and risk factors.
Comments
No comments yet